Company intelligence / Profile preview

Belcynor Pharmaceuticals Inc.

Ownership: Private
Development stage: Commercial

Overview

Belcynor Pharmaceuticals Inc. focuses on providing innovative oncology products to the Filipino market. The company distributes and imports approved chemotherapeutic agents such as paclitaxel and docetaxel, manufactured by Biolyse Pharma. It also facilitates patient access to advanced medicines for various cancers that are otherwise unavailable locally.

Therapeutic areas: Oncology
Modalities: Small molecules (e.g., paclitaxel, docetaxel)Biologics (potentially, as they import "cutting-edge medicines" for cancer patients)
Industry: Non-Academic Healthcare

Drug pipeline

1 asset

nivolumab

Commercial

Indications: Cancer

Partnerships

Biolyse Pharma – manufacturing partner for paclitaxel/docetaxel supply

Beyond the preview

Go deeper on Belcynor Pharmaceuticals Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Belcynor Pharmaceuticals Inc..

Explore the full profile